In the present study of a well‐characterized cohort of healthy and COPD smokers and non‐smokers, we observed that serum levels of MMP‐9, NGAL and proMMP‐9/NGAL were higher in COPD smokers than in COPD non‐smokers. Here, LCN2 is linked to chronic obstructive pulmonary disease.